Status:
COMPLETED
Tolerance of Healthy Term Infants Fed Infant Formulas
Lead Sponsor:
Abbott Nutrition
Conditions:
Infant, Newborn
Eligibility:
All Genders
Up to 8 years
Phase:
PHASE2
Brief Summary
The objective of the study is to assess comparative gastrointestinal tolerance of normal term infants to various milk-protein infant formulas.
Eligibility Criteria
Inclusion
- Healthy, term infants; singleton birth; 37-42 weeks of age; \>2490gms at birth; 0-8 days of age
Exclusion
- medications/foods/formulas affecting GI tolerance;adverse medical history with possible effect on tolerance or growth
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
190 Patients enrolled
Trial Details
Trial ID
NCT00705562
Start Date
June 1 2008
End Date
December 1 2008
Last Update
January 5 2009
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
Global Clinical Investigation
Aventura, Florida, United States, 33180
2
University of South Florida
Tampa, Florida, United States, 33606
3
University of Iowa
Coralville, Iowa, United States, 52241
4
Medical Associates Clinic
Dubuque, Iowa, United States, 52002